| According to sources, a leading FII was a buyer at the counter on Monday. The stock has been in the limelight following the optimistic outlook by the management about the future of the company. |
| At an analysts' meet held on Thursday, Ranbaxy's management said the company is on track to achieve global sales of $2 billion by 2007 with a 20 per cent CAGR between 2003 and 2007. |
| Its global sales stood at $972 million in 2003 (year ended December 31, 2003). The management said it has set a goal of achieving global sales of $5 billion by 2012. |
| The stock, after hitting an intra-day high of Rs 1,974.95, closed at Rs 1,069.85, up 4.36 per cent from its previous close. |
| The counter witnessed a volume of over 3.27 lakh shares on the BSE. On the NSE the counter stock witnessed a volume of over 8.7 lakh shares. |
Explore Business Standard